The U-BIOPRED consortium encompasses the representatives of all stakeholder groups by involving partners from academia (20), biopharma industry (EFPIA) (10), patients/care organisations (6), small to medium enterprises (3) and multinational industry (1).
Co-ordinator: Academic Medical Centre, University of Amsterdam, The Netherlands EFPIA co-ordinator: Novartis Pharma AG
Patients have been involved at all stages of the project: as members of the ethics (EB) and safety monitoring boards (SMB), in the Patient Involvement Platform (PIP), and as participants. Read more about patient participation in U-BIOPRED.
Visit the information page for details on the boards and their functions.
For further information on a specific consortium member click on their logo below: